Skip to main content

International Trade Commission Affirms ALJ Finding That 3Shape Infringes Three Align Patents but Declines to Find Section 337 Violation

Written by Customer Service on . Posted in Public Companies.

ALJ and Commission Both Find 3Shape Infringes Four Claims from Three Align PatentsCommission Declines to Find Violation; Align Reviewing Decision and Will Consider Appropriate Response, Including Possible Federal Circuit AppealFive Other Patent Infringement Cases in Delaware Federal District Court Alleging Infringement of Different Patents Not Included in Current ITC investigations are Not Stayed and are in Active LitigationSAN JOSE, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) announced today that on November 22, 2019 the United States International Trade Commission (ITC) issued an Opinion reviewing an Administrative Law Judge’s Initial Determination in his investigation of 3Shape’s infringement of Align’s patents. Like the ALJ, the Commission Opinion determined that 3Shape infringes four claims from three Align patents, but declined to find a violation of Section 337 because, based on the ALJ’s adopted claim construction, it found that Align’s own products do not practice the claims (a requirement unique to the ITC) and that certain claims are invalid.“While we are pleased that both the ALJ and now the full Commission have found that 3Shape infringes multiple claims from multiple Align patents, we are disappointed that the Commission decision results in no exclusion order for 3Shape’s infringement. We are considering all appropriate options, including a possible appeal to the Federal Circuit,” said Julie Coletti, senior vice president, chief legal and regulatory officer. “The Commission decision confirms our belief that 3Shape infringes Align’s core patents regarding color intraoral scanning technology. As always, we remain committed to protecting our significant investment in innovation.”The parallel federal district court case filed by Align in Delaware, alleging infringement of the same patents but where the requirement that Align practice the patents does not apply, will remain stayed pending any related appeals. Five other patent infringement cases in Delaware federal district court alleging infringement of different Align patents not included in this ITC investigation are not stayed and are in active litigation, with the first trials scheduled for April and June 2020.About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align’s products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit www.aligntech.com for more information.For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.